NFKB1 and brain ischemia: In stroke-induced brain ischemia in rats, SB was able to significantly decrease the expression of Bax and NF-κB, simultaneously with the upregulation of Akt, mTOR, HIF-1α and Bcl-2, leading to the mitigation of neurological deficits, reduced infarct volume and suppressed brain oedema [165].